<--- Back to Details
First PageDocument Content
Bevacizumab / Brain tumor / Glioblastoma multiforme / University of Texas MD Anderson Cancer Center / Management of cancer / Colorectal cancer / Daniel Von Hoff / Prostate cancer / Medicine / Oncology / Cancer organizations
Date: 2014-05-31 07:25:26
Bevacizumab
Brain tumor
Glioblastoma multiforme
University of Texas MD Anderson Cancer Center
Management of cancer
Colorectal cancer
Daniel Von Hoff
Prostate cancer
Medicine
Oncology
Cancer organizations

Fall 2013 VOL 28 ISSUE 1 CONQUEST LOOKING

Add to Reading List

Source URL: www.mdanderson.org

Download Document from Source Website

File Size: 4,62 MB

Share Document on Facebook

Similar Documents

United States Government Accountability Office  GAO Report to the Ranking Member, Committee on Finance, U.S. Senate

United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. Senate

DocID: 1riEa - View Document

Lettre d’information du réseau GCO - Spéciale ASCOLes Groupes Coopérateurs en Oncologie à l’ASCO 2016 Les Groupes Coopérateurs en Oncologie (GCO) seront représentés au 52ème congrès de l’ASCO (Ameri

Lettre d’information du réseau GCO - Spéciale ASCOLes Groupes Coopérateurs en Oncologie à l’ASCO 2016 Les Groupes Coopérateurs en Oncologie (GCO) seront représentés au 52ème congrès de l’ASCO (Ameri

DocID: 1qX2r - View Document

References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

DocID: 1qSc2 - View Document

CURRICULUM VITAE Mary W. Redman, Ph.D.  Current Address:

CURRICULUM VITAE Mary W. Redman, Ph.D. Current Address:

DocID: 1qCPH - View Document

CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

DocID: 1pDeC - View Document